Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumerlab.com

This article was originally published in The Tan Sheet

Executive Summary

Online testing firm announces 20 of 21 alpha-lipoic acid supplements evaluated for label contents contained their stated amount of the active ingredient; only Genesis Super Alpha Lipoic Acid 100 mg failed. "None of the products contained unacceptable levels of lead and none failed to break apart properly - which is necessary for absorption," the White Plains, N.Y.-based Consumerlab.com adds. Supplements from Jarrow Formulas, Solgar, Sundown and Twinlab were among the passing products...

You may also be interested in...



BioMarin All Set For Hemophilia Gene Therapy Approval, But Is It Overestimating Demand?

Analysts forecast a slow climb towards peak sales of $2bn – but competitors could erode that figure.

Device Week, 27 February 2020 – The Risky Business Of Bringing ISO 14971:2019 Into Quality Systems

On this week’s podcast, executive editor Shawn M. Schmitt shares expert tips and advice on how device makers can integrate the recently revised international risk management standard ISO 14971 into their quality systems.

Start-Up Snapshot: Alpha Tau Hopes For A Breakthrough In Radiotherapy

Alpha Tau is looking to change the global radiation therapy paradigm. The Israeli start-up is developing Alpha DaRT, a novel technology for delivering alpha radiation for local tumor destruction.

Topics

UsernamePublicRestriction

Register

PS097680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel